Anti-TMEM150B antibodies are used in the immunodetection of the protein transmembrane protein 150B. In humans, the canonical protein has a reported length of 233 amino acid residues and a mass of 25.7 kDa. Its subcellular localization is in the cytoplasmic vesicles and cell membrane. It is reported to be highly expressed in the colon and lung with comparatively high levels also detectable in the lymph nodes, placenta, duodenum, peripheral blood mononuclear cells and spleen. A member of the DRAM/TMEM150 protein family, TMEM150B is known to be involved with autophagy pathways. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include DRAM-Related/Associated Member 3, hCG1651476, protein DRAM-3, tentonin 2, transmembrane protein 224, and modulator of macroautophagy TMEM150B. TMEM150B gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chimpanzee species. Western Blot is the most common application for the TMEM150B antibodies listed below. ELISA, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are also common applications.